226 related articles for article (PubMed ID: 14615372)
1. Hoxa9 influences the phenotype but not the incidence of Mll-AF9 fusion gene leukemia.
Kumar AR; Hudson WA; Chen W; Nishiuchi R; Yao Q; Kersey JH
Blood; 2004 Mar; 103(5):1823-8. PubMed ID: 14615372
[TBL] [Abstract][Full Text] [Related]
2. Leukemic transformation of hematopoietic progenitors by MLL-GAS7 in the absence of Hoxa7 or Hoxa9.
So CW; Karsunky H; Wong P; Weissman IL; Cleary ML
Blood; 2004 Apr; 103(8):3192-9. PubMed ID: 15070702
[TBL] [Abstract][Full Text] [Related]
3. MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele.
Thiel AT; Blessington P; Zou T; Feather D; Wu X; Yan J; Zhang H; Liu Z; Ernst P; Koretzky GA; Hua X
Cancer Cell; 2010 Feb; 17(2):148-59. PubMed ID: 20159607
[TBL] [Abstract][Full Text] [Related]
4. Targeted down-regulation of MLL-AF9 with antisense oligodeoxyribonucleotide reduces the expression of the HOXA7 and -A10 genes and induces apoptosis in a human leukemia cell line, THP-1.
Kawagoe H; Kawagoe R; Sano K
Leukemia; 2001 Nov; 15(11):1743-9. PubMed ID: 11681416
[TBL] [Abstract][Full Text] [Related]
5. Regulation of HOXA9 activity by predominant expression of DACH1 against C/EBPα and GATA-1 in myeloid leukemia with MLL-AF9.
Lee JW; Kim HS; Hwang J; Kim YH; Lim GY; Sohn WJ; Yoon SR; Kim JY; Park TS; Oh SH; Park KM; Choi SU; Ryoo ZY; Lee S
Biochem Biophys Res Commun; 2012 Sep; 426(3):299-305. PubMed ID: 22902925
[TBL] [Abstract][Full Text] [Related]
6. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
[TBL] [Abstract][Full Text] [Related]
7. PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
Li Z; Chen P; Su R; Hu C; Li Y; Elkahloun AG; Zuo Z; Gurbuxani S; Arnovitz S; Weng H; Wang Y; Li S; Huang H; Neilly MB; Wang GG; Jiang X; Liu PP; Jin J; Chen J
Cancer Res; 2016 Feb; 76(3):619-29. PubMed ID: 26747896
[TBL] [Abstract][Full Text] [Related]
8. Plzf drives MLL-fusion-mediated leukemogenesis specifically in long-term hematopoietic stem cells.
Ono R; Masuya M; Nakajima H; Enomoto Y; Miyata E; Nakamura A; Ishii S; Suzuki K; Shibata-Minoshima F; Katayama N; Kitamura T; Nosaka T
Blood; 2013 Aug; 122(7):1271-83. PubMed ID: 23838347
[TBL] [Abstract][Full Text] [Related]
9. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis.
Muntean AG; Tan J; Sitwala K; Huang Y; Bronstein J; Connelly JA; Basrur V; Elenitoba-Johnson KS; Hess JL
Cancer Cell; 2010 Jun; 17(6):609-21. PubMed ID: 20541477
[TBL] [Abstract][Full Text] [Related]
10. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis.
Tan J; Jones M; Koseki H; Nakayama M; Muntean AG; Maillard I; Hess JL
Cancer Cell; 2011 Nov; 20(5):563-75. PubMed ID: 22094252
[TBL] [Abstract][Full Text] [Related]
11. MLL-AF9- and HOXA9-mediated acute myeloid leukemia stem cell self-renewal requires JMJD1C.
Zhu N; Chen M; Eng R; DeJong J; Sinha AU; Rahnamay NF; Koche R; Al-Shahrour F; Minehart JC; Chen CW; Deshpande AJ; Xu H; Chu SH; Ebert BL; Roeder RG; Armstrong SA
J Clin Invest; 2016 Mar; 126(3):997-1011. PubMed ID: 26878175
[TBL] [Abstract][Full Text] [Related]
12. Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes.
Lillico R; Lawrence CK; Lakowski TM
J Proteome Res; 2018 Aug; 17(8):2657-2667. PubMed ID: 29972300
[TBL] [Abstract][Full Text] [Related]
13. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
[TBL] [Abstract][Full Text] [Related]
14. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization.
Popovic R; Riesbeck LE; Velu CS; Chaubey A; Zhang J; Achille NJ; Erfurth FE; Eaton K; Lu J; Grimes HL; Chen J; Rowley JD; Zeleznik-Le NJ
Blood; 2009 Apr; 113(14):3314-22. PubMed ID: 19188669
[TBL] [Abstract][Full Text] [Related]
15. Histone Acetyltransferase Activity of MOF Is Required for
Valerio DG; Xu H; Chen CW; Hoshii T; Eisold ME; Delaney C; Cusan M; Deshpande AJ; Huang CH; Lujambio A; Zheng YG; Zuber J; Pandita TK; Lowe SW; Armstrong SA
Cancer Res; 2017 Apr; 77(7):1753-1762. PubMed ID: 28202522
[TBL] [Abstract][Full Text] [Related]
16. HOXA9 is required for survival in human MLL-rearranged acute leukemias.
Faber J; Krivtsov AV; Stubbs MC; Wright R; Davis TN; van den Heuvel-Eibrink M; Zwaan CM; Kung AL; Armstrong SA
Blood; 2009 Mar; 113(11):2375-85. PubMed ID: 19056693
[TBL] [Abstract][Full Text] [Related]
17. MEIS1 regulates an HLF-oxidative stress axis in MLL-fusion gene leukemia.
Roychoudhury J; Clark JP; Gracia-Maldonado G; Unnisa Z; Wunderlich M; Link KA; Dasgupta N; Aronow B; Huang G; Mulloy JC; Kumar AR
Blood; 2015 Apr; 125(16):2544-52. PubMed ID: 25740828
[TBL] [Abstract][Full Text] [Related]
18. Functional specificity of CpG DNA-binding CXXC domains in mixed lineage leukemia.
Risner LE; Kuntimaddi A; Lokken AA; Achille NJ; Birch NW; Schoenfelt K; Bushweller JH; Zeleznik-Le NJ
J Biol Chem; 2013 Oct; 288(41):29901-10. PubMed ID: 23990460
[TBL] [Abstract][Full Text] [Related]
19. MLL is essential for NUP98-HOXA9-induced leukemia.
Shima Y; Yumoto M; Katsumoto T; Kitabayashi I
Leukemia; 2017 Oct; 31(10):2200-2210. PubMed ID: 28210005
[TBL] [Abstract][Full Text] [Related]
20. Learning from mouse models of MLL fusion gene-driven acute leukemia.
Schwaller J
Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
